Surrogate electroretinographic markers for assessing therapeutic efficacy in the retina

Expert Review of Molecular Diagnostics
David G Birch

Abstract

Visual acuity remains the primary surrogate marker for clinical trials in ophthalmology (and the primary outcome for most US Food and Drug Administration applications) due to its long history, ease of measurement and clear relationship to clinically meaningful characteristics of daily life. However, treatment trials are being planned for diseases that are currently untreatable where visual acuity may not be the most appropriate outcome measure. Specialized electroretinographic tests can be powerful surrogate markers in such trials. The selection of outcome measures and surrogate markers depends in part on whether the goal is to preserve remaining vision in a progressive retinal degeneration or to improve vision in an eye that has already undergone extensive degeneration. Among the electroretinographic tests available are those involving the whole retina (full-field electroretinographic), the posterior pole (pattern electroretinographic) or focal areas within the macula (multifocal electroretinographic). The advantages and disadvantages of each will be discussed along with selected applications of each test to a specific category of disease.

References

Oct 1, 1977·Archives of Ophthalmology·M A Sandberg, M Ariel
Nov 1, 1976·American Journal of Optometry and Physiological Optics·I L Bailey, J E Lovie
Aug 15, 1989·American Journal of Ophthalmology·A HeijlG Lindgren
Jul 1, 1988·Documenta Ophthalmologica. Advances in Ophthalmology·D G Birch, G E Fish
Mar 1, 1987·Documenta Ophthalmologica. Advances in Ophthalmology·E Dodt
Nov 1, 1986·The British Journal of Ophthalmology·J SalzmanL Yannuzzi
Jul 1, 1982·American Journal of Ophthalmology·F L FerrisI Bailey
Jun 1, 1993·Archives of Ophthalmology·E L BersonW Willett
Oct 1, 1996·Ophthalmology·S GroverD J Derlacki
May 1, 1997·Visual Neuroscience·D C HoodV Greenstein
Jan 1, 1996·Documenta Ophthalmologica. Advances in Ophthalmology·D C Hood, D G Birch
Jan 1, 1996·Documenta Ophthalmologica. Advances in Ophthalmology·D G Birch, M A Sandberg
May 7, 2002·American Journal of Ophthalmology·David J Browning
Sep 26, 2003·The British Journal of Ophthalmology·Y RotenstreichD G Birch

❮ Previous
Next ❯

Citations

Apr 29, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Samuel G JacobsonWilliam W Hauswirth
Aug 25, 2020·British Journal of Pharmacology·Annette E AllenWilliam S Redfern

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Klinische Monatsblätter für Augenheilkunde
U KretschmannE Zrenner
Current Opinion in Ophthalmology
Paul S Baker, Gary C Brown
British Journal of Hospital Medicine
G W Aylward
© 2021 Meta ULC. All rights reserved